UniCredit S.p.A. Unsponsored ADR (OTCMKTS:UNCRY) Short Interest Up 73.7% in July

Key Points

• Short interest in UniCredit S.p.A. saw a dramatic increase of 73.7% in July, totaling 122,800 shares by July 31, up from 70,700 shares mid-month.
• UniCredit's current stock price is $40.72, showing a slight increase of 0.8%, with a 52-week range between $18.70 and $40.74.
• Analyst firm Keefe, Bruyette & Woods downgraded UniCredit from a "moderate buy" to a "hold" rating as of May 15.

UniCredit S.p.A. Unsponsored ADR (OTCMKTS:UNCRY - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 122,800 shares, agrowthof73.7% from the July 15th total of 70,700 shares. Based on an average trading volume of 501,500 shares, the days-to-cover ratio is currently 0.2 days. Currently,0.0% of the shares of the stock are short sold. Currently,0.0% of the shares of the stock are short sold. Based on an average trading volume of 501,500 shares, the days-to-cover ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Keefe, Bruyette & Woods downgraded UniCredit from a "moderate buy" rating to a "hold" rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, UniCredit currently has a consensus rating of "Buy".

UniCredit Price Performance

UNCRY traded up $0.35 on Friday, hitting $40.46. 162,554 shares of the company were exchanged, compared to its average volume of 254,095. UniCredit has a 12 month low of $18.70 and a 12 month high of $40.74. The firm has a fifty day simple moving average of $35.69 and a two-hundred day simple moving average of $31.05.

UniCredit Company Profile

UniCredit S.p.A. provides commercial banking services in Italy, Germany, Central Europe, and Eastern Europe. It offers retail, private, and wealth management solutions; and institutional investor solutions. The company also provides corporate finance advisory, rating advisory, financial sponsor, patient capital, capital structure advisory, and finance solutions, as well as securities services.